Skip to content

Comprehensive study on the health promotion effect by continuous ingestion of peanuts for 8 weeks

Comprehensive study on the health promotion effect by continuous ingestion of peanuts for 8 weeks - Comprehensive study on the health promotion effect by continuous ingestion of peanuts for 8 weeks

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000027178
Enrollment
20
Registered
2017-04-28
Start date
2017-05-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Interventions

Ingest peanuts 27.5 g/day for 8 continuous weeks

Sponsors

Denroku Co., Ltd.
Lead Sponsor
Healthcare Systems Co., Ltd. Aichi Gakuin University
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document 2. Healthy Japanese women who is 30 years old or more and less than 60 years old 3. Persons whose BMI is 23 or more

Exclusion criteria

Exclusion criteria: 1. Persons with the severe disease medical history 2. Persons who are allergic to the test food 3. Persons who have participated in other tests within the first month before the start of the test, or those who intend to participate in another exam after consenting to this exam 4. Persons who are pregnant, breastfeeding, planning or hoping to be pregnant during the study period 5. Persons who were judged as inappropriate for subjects by the principal investigator

Design outcomes

Primary

MeasureTime frame
Obesity related factor

Secondary

MeasureTime frame
Self-aware questionnaire, blood test (general biochemical test), blood oxidative stress marker, blood glycation marker, urine putrid substance, intestinal flora

Countries

Japan

Contacts

Public ContactHirohito Ishikawa

Healthcare Systems Co., Ltd. Research and Development

ishikawa@hc-sys.jp03-6809-2722

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026